Evidence map›Paper›PMID 41450943›Full record

ArticleFrontiers in microbiology2025

Physiological stage-dependent effects of

Monica Selena Fonseca-Perez, Oscar Villavicencio-Carrisoza, Orly Grobeisen-Duque, Luis Antonio Herrera-Moro-Huitron, Arturo Flores-Pliego, Aurora Espejel-Nuñez, Andrea Olmos-Ortiz, Belen Betsaida Del-Castillo-Hernandez, Jose Ramon Rojo-Garcia, Sandra Rivera-Gutierrez and 6 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Monica Selena Fonseca-PerezDepartamento de Inmunobioquímica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.
Oscar Villavicencio-CarrisozaDepartamento de Medicina Traslacional, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.
Orly Grobeisen-DuqueDepartamento de Inmunobioquímica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.
Luis Antonio Herrera-Moro-HuitronDepartamento de Inmunobioquímica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.
Arturo Flores-PliegoDepartamento de Inmunobioquímica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.
Aurora Espejel-NuñezDepartamento de Inmunobioquímica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.
Andrea Olmos-OrtizDepartamento de Inmunobioquímica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.
Belen Betsaida Del-Castillo-HernandezDepartamento de Anatomía Patológica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.
Jose Ramon Rojo-GarciaDepartamento de Anatomía Patológica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.
Sandra Rivera-GutierrezEscuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Jorge Francisco Cerna-CortesEscuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Veronica Zaga-ClavellinaDirección de Investigación, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.
Maria Isabel Villegas-MotaSecretaría de Salud del Estado de Quintana Roo, Chetumal, Mexico.
Diana Angelica Aguilar-AyalaDepartamento de Inmunobioquímica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.
Maria Yolotzin Valdespino-VazquezNuffield Department of Women's and Reproductive Health NDWRH, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Addy Cecilia Helguera-RepettoDepartamento de Inmunobioquímica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tuberculosis (TB) poses a significant risk during pregnancy and the postpartum period, with evidence linking these stages to an increased likelihood of progression from latent TB infection to active disease. Although TB has been associated with adverse pregnancy outcomes, including congenital transmission, the mechanisms by which Objective: This study aimed to investigate the stage-dependent effects of Mtb infection on human placental tissue and assess the potential for vertical transmission using an Methods: Human term placental explants were infected Results: Mtb in rNRP1 and rNRP2 phases replicated efficiently within placental explants, with CFU increasing by more than one log at 48 h. rNRP2 exhibited delayed tissue entry (only 4% at 24 h), suggesting distinct virulence dynamics based on bacterial phase. Both reactivated phases induced villitis, stromal fibrosis, and reduced vascular integrity, with rNRP2 causing the most severe tissue damage. Conclusion: Mtb can infect, persist, and replicate within human placental tissue, compromising its structural and immune integrity. These effects vary with the bacterial physiological phase, with early-reactivated Mtb showing the greatest capacity for tissue dissemination and damage. These findings underscore a dual risk of placental injury and increased potential for vertical transmission during early reactivation, emphasizing the need for timely TB screening and intervention during pregnancy.

Indexed as

congenital tuberculosiscytokines expressionmetalloproteinases actionMtb virulenceplacental disruptionplacental infectionreactivation from hypoxia

Identifiers

PMID41450943
PMCPMC12727939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.